These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Therapeutic strategies for atrial fibrillation. The value of decision analysis. Greenberg ML; Malenka DJ; Disch DL Cardiol Clin; 1996 Nov; 14(4):623-40. PubMed ID: 8950062 [TBL] [Abstract][Full Text] [Related]
7. How should we manage newly diagnosed atrial fibrillation? Holten KB J Fam Pract; 2004 Aug; 53(8):641-3. PubMed ID: 15298837 [No Abstract] [Full Text] [Related]
8. [The treatment of atrial fibrillation]. Halinen MO Duodecim; 1995; 111(8):705-13. PubMed ID: 8681830 [No Abstract] [Full Text] [Related]
9. Atrial fibrillation and anticoagulation. Marcus RR; Atwood JE Adv Intern Med; 1999; 44():239-65. PubMed ID: 9929711 [No Abstract] [Full Text] [Related]
10. Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. Al-Khatib SM; Thomas L; Wallentin L; Lopes RD; Gersh B; Garcia D; Ezekowitz J; Alings M; Yang H; Alexander JH; Flaker G; Hanna M; Granger CB Eur Heart J; 2013 Aug; 34(31):2464-71. PubMed ID: 23594592 [TBL] [Abstract][Full Text] [Related]
11. [Atrial fibrillation due to non-valvular causes: indications for antithrombotic therapy]. Codinach Huix P Med Clin (Barc); 1996 Apr; 106(15):586-9. PubMed ID: 8656759 [No Abstract] [Full Text] [Related]
12. Value of precardioversion transesophageal echocardiography in managing cardioversion in atrial fibrillation. Manning WJ; Silverman DI; Seto TB; Weigner MJ J Am Coll Cardiol; 2002 Nov; 40(10):1889; author reply 1889-90. PubMed ID: 12446076 [No Abstract] [Full Text] [Related]
13. Atrial fibrillation: prevalence and management in an acute general medical unit. Stewart FM; Singh Y; Persson S; Gamble GD; Braatvedt GD Aust N Z J Med; 1999 Feb; 29(1):51-8. PubMed ID: 10200813 [TBL] [Abstract][Full Text] [Related]
15. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis. Andersen LV; Vestergaard P; Deichgraeber P; Lindholt JS; Mortensen LS; Frost L Heart; 2008 Dec; 94(12):1607-13. PubMed ID: 18208828 [TBL] [Abstract][Full Text] [Related]
16. [Pharma-clinics. How I treat... a patient with atrial fibrillation. 2]. Soyeur D Rev Med Liege; 1995 Aug; 50(8):313-4. PubMed ID: 7481256 [No Abstract] [Full Text] [Related]
17. Prevalence of inappropriate use of digoxin in 136 patients on digoxin and prevalence of use of warfarin or aspirin in 89 patients with persistent or paroxysmal atrial fibrillation. Lleva P; Aronow WS; Gutwein AH Am J Ther; 2009; 16(6):e41-3. PubMed ID: 19940604 [TBL] [Abstract][Full Text] [Related]
18. Early cardioversion of atrial fibrillation and atrial flutter guided by transoesophageal echocardiography: a single centre 8.5-year experience. Corrado G; Santarone M; Beretta S; Tadeo G; Tagliagambe LM; Foglia-Manzillo G; Spata M; Miglierina E; Acquati F; Santarone M Europace; 2000 Apr; 2(2):119-26. PubMed ID: 11225938 [TBL] [Abstract][Full Text] [Related]
19. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL; Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169 [TBL] [Abstract][Full Text] [Related]
20. Benefits and risks of thrombolytic, anticoagulant and antiplatelet therapies in atrial fibrillation. Marchant BG; Timmis AD Br J Hosp Med; 1993 Feb 3-16; 49(3):186-90. PubMed ID: 8439785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]